Sildenafil Teva
From £3.99
Clinical Evidence and Mechanism of Action
Discovery and Development
Sildenafil was initially researched as a treatment for pulmonary arterial hypertension and angina. During clinical trials in the 1990s, researchers observed its effects on erectile function, leading to extensive studies specifically for erectile dysfunction. This serendipitous discovery resulted in rigorous clinical testing that established sildenafil as an effective treatment option.
How Sildenafil Works
Clinical research has demonstrated that sildenafil works by inhibiting phosphodiesterase type 5 (PDE5), an enzyme that breaks down cyclic guanosine monophosphate (cGMP). When sexual arousal occurs, nitric oxide is released in penile tissue, increasing cGMP levels. By blocking PDE5, sildenafil allows cGMP to accumulate, promoting smooth muscle relaxation and increased blood flow to the penis.
Clinical Trial Results
Multiple randomised controlled trials have evaluated sildenafil's effectiveness. Studies consistently show that 60-80% of men experience improved erections compared to 20-25% with placebo. Research indicates that effectiveness may vary based on underlying causes of erectile dysfunction, with diabetic patients showing slightly lower response rates than those with psychological or vascular causes.
Pharmacokinetics Research
Clinical studies demonstrate that sildenafil reaches peak blood levels within 30-120 minutes of oral administration. Food, particularly high-fat meals, can delay absorption by up to 60 minutes. The medication has a half-life of approximately 4 hours, though effects on erectile function may persist longer in some individuals.
Safety Profile
Extensive safety data from clinical trials involving thousands of participants has established sildenafil's cardiovascular safety profile in appropriate candidates. Research shows that when properly prescribed following clinical assessment, serious adverse events are rare. Common side effects reported in trials include headache (16%), facial flushing (10%), and nasal congestion (4%).
Branded vs Generic Options
Clinical research applies equally to both Viagra (branded sildenafil) and generic formulations, as they contain the same active ingredient in identical doses. EverydayMeds offers both options, allowing patients to choose between branded Viagra or more cost-effective generic sildenafil following online consultation with UK-licensed prescribers.
Dosing Research
Clinical studies established optimal starting doses of 50mg for most patients, with adjustments to 25mg or 100mg based on individual response and tolerability. Research confirms that exceeding recommended doses does not improve effectiveness but may increase side effect risk.
